ONEMEDNET CORP(NASDAQ:ONMD) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to ONMD. ONMD was compared to 39 industry peers in the Health Care Technology industry. ONMD has a bad profitability rating. Also its financial health evaluation is rather negative. ONMD is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ONMD has reported negative net income.

ONMD had a positive operating cash flow in the past year.

1.2 Ratios

The Return On Assets of ONMD (-684.91%) is worse than 97.30% of its industry peers.

		Industry Rank	Sector Rank
ROA	-684.91%
ROE	N/A
ROIC	N/A

ROA(3y)-1675.81%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ONMD so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ONMD does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ONMD has been increased compared to 1 year ago.

Compared to 1 year ago, ONMD has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -44.67, we must say that ONMD is in the distress zone and has some risk of bankruptcy.

ONMD's Altman-Z score of -44.67 is on the low side compared to the rest of the industry. ONMD is outperformed by 97.30% of its industry peers.

ONMD has a debt to FCF ratio of 1.13. This is a very positive value and a sign of high solvency as it would only need 1.13 years to pay back of all of its debts.

ONMD has a better Debt to FCF ratio (1.13) than 81.08% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	1.13
Altman-Z	-44.67

ROIC/WACCN/A

WACC7.97%

2.3 Liquidity

A Current Ratio of 0.23 indicates that ONMD may have some problems paying its short term obligations.

ONMD has a Current ratio of 0.23. This is amonst the worse of the industry: ONMD underperforms 94.59% of its industry peers.

ONMD has a Quick Ratio of 0.23. This is a bad value and indicates that ONMD is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.23, ONMD is doing worse than 94.59% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.23
Quick Ratio	0.23

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.91% over the past year.

The Revenue has grown by 140.98% in the past year. This is a very strong growth!

EPS 1Y (TTM)3.91%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%93.16%

Revenue 1Y (TTM)140.98%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-79.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ONMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ONMD indicates a rather cheap valuation: ONMD is cheaper than 94.59% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	5.39
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ONMD!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ONEMEDNET CORP

NASDAQ:ONMD (2/21/2025, 8:00:02 PM)

After market: 0.99 0 (0%)

0.99

+0.02 (+2.27%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners15.31%

Inst Owner Change-29.4%

Ins Owners38.44%

Ins Owner Change0%

Market Cap27.71M

AnalystsN/A

Price TargetN/A

Short Float %1.15%

Short Ratio0.7

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	16.91
P/FCF	5.39
P/OCF	3.47
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-1.26

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.18

FCFY18.57%

OCF(TTM)0.28

OCFY28.78%

SpS0.06

BVpS-0.51

TBVpS-0.51

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-684.91%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	313.99%

ROA(3y)-1675.81%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score7

Asset Turnover0.37

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	1.13
Debt/EBITDA	N/A
Cap/Depr	7259.52%
Cap/Sales	172.69%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.23
Quick Ratio	0.23
Altman-Z	-44.67

F-Score7

WACC7.97%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)3.91%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%93.16%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)140.98%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-79.12%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-76.62%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y684.68%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y1006.24%

OCF growth 3YN/A

OCF growth 5YN/A

ONEMEDNET CORP (ONMD) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens